These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 1448491)

  • 1. Effect of oxiracetam on scopolamine-induced amnesia in the rat in a spatial learning task.
    Pitsikas N; Algeri S
    Pharmacol Biochem Behav; 1992 Nov; 43(3):949-51. PubMed ID: 1448491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxiracetam antagonizes the disruptive effects of scopolamine on memory in the radial maze.
    Magnani M; Pozzi O; Biagetti R; Banfi S; Dorigotti L
    Psychopharmacology (Berl); 1992; 106(2):175-8. PubMed ID: 1549645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of DAU 6215, a novel 5-HT3 receptor antagonist, on scopolamine-induced amnesia in the rat in a spatial learning task.
    Pitsikas N; Brambilla A; Borsini F
    Pharmacol Biochem Behav; 1994 Jan; 47(1):95-9. PubMed ID: 8115433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of scopolamine and nootropic drugs on rewarded alternation in a T-maze.
    Bartolini L; Risaliti R; Pepeu G
    Pharmacol Biochem Behav; 1992 Dec; 43(4):1161-4. PubMed ID: 1475299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of acute doses of oxiracetam in the scopolamine model of human amnesia.
    Preda L; Alberoni M; Bressi S; Cattaneo C; Parini J; Canal N; Franceschi M
    Psychopharmacology (Berl); 1993; 110(4):421-6. PubMed ID: 7870912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A decrease in brain catecholamines prevents oxiracetam antagonism of the effects of scopolamine on memory and brain acetylcholine.
    Giovannini MG; Spignoli G; Carlà V; Pepeu G
    Pharmacol Res; 1991 Dec; 24(4):395-405. PubMed ID: 1805193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The interaction of L-deprenyl and scopolamine on spatial learning/memory in rats.
    Yavich L; Sirviö J; Heinonen E; Riekkinen P
    J Neural Transm Park Dis Dement Sect; 1993; 6(3):189-97. PubMed ID: 8123192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxiracetam prevented the scopolamine but not the diazepam induced memory deficits in mice.
    Hlinák Z; Krejcí I
    Behav Brain Res; 2002 Jul; 133(2):395-9. PubMed ID: 12110475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of vasoactive intestinal peptide (VIP) on scopolamine-induced amnesia in the rat.
    Yamaguchi Y; Kobayashi H
    Neuropeptides; 1994 Mar; 26(3):153-8. PubMed ID: 8208360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Attenuation of scopolamine-induced spatial memory deficits in the rat by cholinomimetic and non-cholinomimetic drugs using a novel task in the 12-arm radial maze.
    Dennes RP; Barnes JC
    Psychopharmacology (Berl); 1993; 111(4):435-41. PubMed ID: 7870985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of ascorbic acid and oxiracetam on scopolamine-induced amnesia in a habituation test in aged mice.
    de Angelis L; Furlan C
    Neurobiol Learn Mem; 1995 Sep; 64(2):119-24. PubMed ID: 7582819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of huperzine A, a novel acetylcholinesterase inhibitor, on radial maze performance in rats.
    Xiong ZQ; Tang XC
    Pharmacol Biochem Behav; 1995; 51(2-3):415-9. PubMed ID: 7667362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antagonism of scopolamine-induced memory impairments in rats by the muscarinic agonist RU 35,926 (CI-979).
    M'Harzi M; Palou AM; Oberlander C; Barzaghi F
    Pharmacol Biochem Behav; 1995 May; 51(1):119-24. PubMed ID: 7617721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bidirectional modulation of scopolamine-induced working memory impairments by muscarinic activation of the medial septal area.
    Givens B; Olton DS
    Neurobiol Learn Mem; 1995 May; 63(3):269-76. PubMed ID: 7670840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rolipram and its optical isomers, phosphodiesterase 4 inhibitors, attenuated the scopolamine-induced impairments of learning and memory in rats.
    Egawa T; Mishima K; Matsumoto Y; Iwasaki K; Iwasaki K; Fujiwara M
    Jpn J Pharmacol; 1997 Nov; 75(3):275-81. PubMed ID: 9434259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancement of hippocampally-mediated learning and protein kinase C activity by oxiracetam in learning-impaired DBA/2 mice.
    Fordyce DE; Clark VJ; Paylor R; Wehner JM
    Brain Res; 1995 Feb; 672(1-2):170-6. PubMed ID: 7749739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interactions between oxiracetam, aniracetam and scopolamine on behavior and brain acetylcholine.
    Spignoli G; Pepeu G
    Pharmacol Biochem Behav; 1987 Jul; 27(3):491-5. PubMed ID: 3659072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of (R)-alpha-methylhistamine and scopolamine on spatial learning in the rat assessed using a water maze.
    Smith CP; Hunter AJ; Bennett GW
    Psychopharmacology (Berl); 1994 May; 114(4):651-6. PubMed ID: 7855228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relationship between the behavioral effects of cognition-enhancing drugs and brain acetylcholine. Nootropic drugs and brain acetylcholine.
    Pepeu G; Spignoli G; Giovannini MG; Magnani M
    Pharmacopsychiatry; 1989 Oct; 22 Suppl 2():116-9. PubMed ID: 2602443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dissociation of cholinergic function in spatial and procedural learning in rats.
    von Linstow Roloff E; Harbaran D; Micheau J; Platt B; Riedel G
    Neuroscience; 2007 May; 146(3):875-89. PubMed ID: 17418958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.